Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NICE seeks uro/gynae expert for interventional procedures committee:

This article was originally published in Clinica

Executive Summary

The Interventional Procedures Advisory Committee (IPAC) of the UK's National Institute for Health and Clinical Excellence (NICE) is seeking an expert in gynaecology or urogynaecology to replace a member who is stepping down in September. IPAC assesses R&D evidence to advise NICE on the safety and efficacy of new or rare interventional (surgical, endoscopic and radiological) procedures. The recommendations form the basis of NICE's guidance on these for the NHS in the whole of the UK. The closing date for applications is September 14 2007, and should be sent to Interventional Procedures Programme associate director Mirella Marlow (mirella.marlow@nice.org.uk).

You may also be interested in...



EMA Panexcell Review Leads Tillomed To Pull Doxorubicin

Emcure’s Tillomed has been forced to withdraw its application for a version of doxorubicin, in light of the EMA taking a closer look at medicines for which study data prepared by Panexcell Clinical Laboratories was used to support marketing authorization applications.

UK MHRA Finds Labs Releasing Unreliable Data Under Pressure From Pharma

A UK regulator with the MHRA is concerned that bioanalytical laboratories are not being given enough time to do their job properly by drug companies under pressure to ensure their clinical trials remain on schedule. 

European Firms Adapting To Coronavirus Challenges

Companies across Europe are dealing with new challenges stemming from the coronavirus outbreak, particularly with supply issues due to increased demand. This article details the responses of five consumer health players in the region: Reckitt Benckiser, Zentiva, Vitabiotics, Alliance Pharma and BioGaia.

Topics

UsernamePublicRestriction

Register

MT049526

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel